The case is State of Alabama v. Endo Health Solutions Inc, Montgomery County Circuit Court, Alabama, No. Reuters reported that the participation of Alabama and Nevada was in doubt. For Alabama: Jere Beasley and Rhon Jones of Beasley, Allen, Crow, Methvin, Portis & Miles; and Robert Prince of Prince Glover Hayes. The resolution includes a deferred prosecution agreement and forfeiture totaling $20.8 million and civil false claims settlements with the federal government and the states and the District of Columbia totaling $171.9 million. Alabama is accusing McKesson of failing to prevent the diversion of opioids for illicit purposes, and accused Endo of engaging in deceptive marketing practices that misrepresented the painkillers benefits and downplayed their addictive risks, according to its court filings. According to the complaint, Endo had an agreement with Watson Laboratories Inc.ensuring Endo would not face generic competition for Lidoderm from Watson-related companies from approximately 2012 to 2014. Alabama, which has had among the highest rates of opioid prescriptions of any state, said the companies should be forced to pay to remedy the harms created by opioid addiction. Due to an agreement between the state and its litigating subdivisions, the state will get $15 million, less attorneys fees, and its litigating subdivisions will receive $10 million. The state is one of eight that opted to not settle with McKesson, who along with rivals AmerisourceBergen and Cardinal Health agreed in July to pay $21 billion to resolve thousands of opioid lawsuits by other states and local governments. The $141 million from McKesson will be paid over the course of nine years. Seattle, WA 98111-9411, SEB Investment Management AB v. Endo International plc, et al. Brendan Pierson reports on product liability litigation and on all areas of health care law. Drug overdoses climbed in Alabama during pandemic, Buy newspaper front pages, posters and more. 2023 Advance Local Media LLC. v. Endo International (Lidoderm) Settlement. The state of Alabama has settled with drugmaker Endo International Plc over its alleged role in the opioid epidemic and is now in talks with distributor McKesson Corp. 501 Washington Avenue The hold was announced right when jury selection was set to start. Former Biden Staffers File New Trump Train Lawsuit Against San Marcos, Blog vs YouTube Over Other Websites: How to Choose, Behind the Story of Ghostbed vs. Purple Mattress Lawsuit, Investigation Reveals Goodyears Dunlop D402 Tires Have Caused Dozens of Motorcycle Accidents, Amputees Third Attempt at Holding Medical Personnel Responsible Pays Off. document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() ); Sign up here to get the latest news and updates delivered directly to your inbox. We are unapologetic in our dedication to informing the public and unafraid to call out those who are more focused on profits than peoples safety. All quotes delayed a minimum of 15 minutes. On Monday, the Attorney General announced a $1.5 million distribution to the state's district attorneys to invest in drug courts. Spokespeople for both Alabama Attorney General Steve Marshall's office and Endo declined to comment. The complaint alleged that the agreement resulted in consumers paying hundreds of millions of dollars in supra-competitive prices for Lidoderm and its generic equivalents during that time. U.S. state officials urge support for landmark $26 bln opioid settlement, Drug companies say enough U.S. states join $26 bln opioid settlement to proceed. Endo is not part of that deal, but previously settled lawsuits with either states or counties in New York, Oklahoma, Tennessee, Louisiana, and Ohio for a total of more than $111 million. Alabama settles opioid claims against Endo, in talks with McKesson, McKesson, Endo face multi-billion dollar opioid trial in Alabama. Nate Raymond reports on the federal judiciary and litigation. Is this happening to you frequently? The industry leader for online information for tax, accounting and finance professionals. Class Actions & Multi-District Litigation, Scooter startup Lime sues Hertz for poaching engineers, NFL, Raiders sued by Las Vegas lawyer over Super Bowl ad, Air Canada pilots decry 'embarrassing' pay gap with U.S. after Delta deal, Factbox: Willow oil and gas project in Alaska sparks green opposition, WHO still working to identify the origins of COVID-19, Norway's Equinor buys Suncor Energy UK in $850 million deal, Law firm leaders express the benefit of strategy, culture & adaptability to weather these uncertain times, 2023 State of the Courts Report: Moving toward modernization, US enforcement seeks fraud among emerging, unregulated finance spaces, Recommended change management practices to plan, build, then deploy successful legal tech, Exclusive news, data and analytics for financial market professionals. P.O. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. The case is State of Alabama v. Endo Health Solutions Inc, et al, Montgomery County Circuit Court, Alabama, No. Weitere Informationen ber die Verwendung Ihrer personenbezogenen Daten finden Sie in unserer Datenschutzerklrung und unserer Cookie-Richtlinie. Washington, DC 20036, As the nonpartisan national forum for America's state and territory attorneys general and their staff, NAAG provides collaboration, insight, and expertise to empower and champion America's attorneys general. Please enter your change or describe your request. . All quotes delayed a minimum of 15 minutes. Thomas Sullivan is Editor of Policy and Medicine, President of Rockpointe Corporation, founded in 1995 to provide continuing medical education to healthcare professionals around the world. Reuters, the news and media division of Thomson Reuters, is the worlds largest multimedia news provider, reaching billions of people worldwide every day. Endo then bought off Watson in a settlement agreement, the states said. Certain persons and entities are excluded from the Settlement Class by definition (see 20 of the Notice). Montgomery, AL 36104. IMPORTANT UPDATE Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. Because this website is just a summary, you should review the Notice and Frequently Asked Questions for additional details. If you purchase a product or register for an account through one of the links on our site, we may receive compensation. The settlement funds will be split 50/50 between the state and its subdivisions. The states lawsuit against opioid manufacturer Endo Pharmaceuticals and distributor McKesson Corporation is set for trial starting Nov. 1 in Montgomery County Circuit Court, Lewis said. Our office is prohibited by law from providing private citizens with legal advice, representation, or opinions (Code of Alabama, 1975, Title 36, Chapter 15). All three companies have denied any wrongdoing. Weathersby, et al. She has an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling, graduating with a 4.2/4.0 GPA. 3:19-cv-04157 (N.D. Cal. CV-2019-901174. Create a NAAG account to subscribe to our newsletters or mailing lists. Of those funds, the state will get $15 million minus attorneys' fees and its litigating subdivisions will receive $10 million. Johnson & Johnson: The State of Alabama and its subdivisions will receive $70.3 million this year in a lump-sum payment. Settlement The State of Alabama has reached a settlement with Endo International (ENDP +8.7%) regarding the drugmaker's alleged role in the nation's prescription opioid . A spokesperson for Marshall, a Republican, previously told Reuters that the state opted out of the deal "to pursue its own legal strategy to best address the impact of the opioid crisis on Alabama.". Additional information can also be obtained by contacting the Claims Administrator by calling toll-free 1-844-961-0316; emailing Info@EndoSecuritiesLitigationSettlement.com; or mailing a letter to: SEB Investment Management AB v. They argue that the state cannot establish that they caused the opioid epidemic and that Alabama public nuisance law does not apply to a harm caused by a product, rather than an interference with public property. 12th floor While the state has not said in public filings how much it is seeking, McKesson in an August filing pegged the amount at up to $20 billion, which would dwarf any recovery in an opioid lawsuit so far. The Alabama Legislature will determine the best uses of this funding. Endo Pharmaceutical: The State of Alabama and its subdivisions will receive $25 million this year in a lump-sum payment. Please disable your ad-blocker and refresh. Alabamas case is State of Alabama v. Endo Health Solutions Inc, Montgomery County Circuit Court, Alabama, No. Under the Endo settlement, Alabama will receive the $25 million in a lump-sum payment. Consumer Interest Division: 1-800-392-5658 Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. In response to the filing, Judge J.R. Gaines on Monday set a new trial date of April 18, 2022. v. Endo International (Lidoderm) Settlement. Related: Drug overdoses climbed in Alabama during pandemic, Opioid crisis roars back in Alabama as overdoses rise during pandemic, Opioid overdose deaths rise among Blacks; one Birmingham mother an inspiring model for recovery. McKesson: The State of Alabama and its subdivisions will receive $141 million over nine years. The Notice relates to a settlement of claims in asecurities class action brought by an Endo investor alleging, among other things, that Endo International plc and Endo Health Solutions Inc. (together, Endo) and certain of Endos former employees and officers (collectively, Defendants") violated the federal securities laws by making false and misleading statements and failing to disclose material adverse facts regarding the putative safety and abuse-deterrent properties of Reformulated Opana ER. Court-appointed Lead Plaintiff SEB Investment Management AB, on behalf of itself and the Settlement Class, reached a settlement of the Action withDefendants for $82,500,000 in cash ("Settlement"). Alabama Attorney General Steve Marshall announced the settlements on Tuesday. Under the settlement, Endo will pay the states and promises not to enter into similar reverse-payment agreements in the future. In mid-April 2022, Alabama announced that it reached $276 million in settlements with Johnson & Johnson, McKesson Corp., and Endo International PLC, resolving claims that the companies fueled the opioid crisis. Johnson & Johnson agreed to pay its $70.3 million in a lump-sum payment this year. In accordance with the Courts September 8, 2021 Order, the initial distribution of the net settlement fund took place on October 28, 2021. The state has accused McKesson of failing to prevent the diversion of opioids for illicit purposes, and Endo of engaging in deceptive marketing practices that misrepresented the painkillers' benefits and downplayed their addictive risks. Due to an agreement between the state and its litigating subdivisions,. v. Endo International (Lidoderm) complaint 07-19-19 Alabama et al. by Marshall's office declined to specify exactly how. We envisioned and developed a State plan long before there was any funding to make it a reality, and I am pleased that we can finally put our plan to good use..